医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
28期
25-26
,共2页
厉锋%李文广%张改琴%杨欢%王雪
厲鋒%李文廣%張改琴%楊歡%王雪
려봉%리문엄%장개금%양환%왕설
CA125%CEA AFP%卵巢癌%临床诊断
CA125%CEA AFP%卵巢癌%臨床診斷
CA125%CEA AFP%란소암%림상진단
CA125%CEA. AFP.%Ovarian cancer Clinical diagnosis
目的:探讨CA125、CEA、AFP联合检测在卵巢癌临床诊断中的价值。方法选取来我院就诊的42例卵巢癌患者为观察组,并选取同期就诊的卵巢良性肿瘤患者40例为对照组,采用电化学发光法检测两组患者血清中CA125、CEA及AFP水平,并对两组患者CA125、CEA及AFP水平和阳性率进行比较。结果观察组中血清CA125、CEA及AFP水平均高于对照组,差异有统计学意义(P<0.05),阳性率优于对照组,差异有统计学意义(P<0.05),且CA125、CEA及AFP联合检测的阳性率高于单项检测结果,差异有统计学意义(p<0.05)。结论 CA125、CEA、AFP联合检测有利于提高卵巢癌检出的阳性率,在其临床诊断中具有较高价值。
目的:探討CA125、CEA、AFP聯閤檢測在卵巢癌臨床診斷中的價值。方法選取來我院就診的42例卵巢癌患者為觀察組,併選取同期就診的卵巢良性腫瘤患者40例為對照組,採用電化學髮光法檢測兩組患者血清中CA125、CEA及AFP水平,併對兩組患者CA125、CEA及AFP水平和暘性率進行比較。結果觀察組中血清CA125、CEA及AFP水平均高于對照組,差異有統計學意義(P<0.05),暘性率優于對照組,差異有統計學意義(P<0.05),且CA125、CEA及AFP聯閤檢測的暘性率高于單項檢測結果,差異有統計學意義(p<0.05)。結論 CA125、CEA、AFP聯閤檢測有利于提高卵巢癌檢齣的暘性率,在其臨床診斷中具有較高價值。
목적:탐토CA125、CEA、AFP연합검측재란소암림상진단중적개치。방법선취래아원취진적42례란소암환자위관찰조,병선취동기취진적란소량성종류환자40례위대조조,채용전화학발광법검측량조환자혈청중CA125、CEA급AFP수평,병대량조환자CA125、CEA급AFP수평화양성솔진행비교。결과관찰조중혈청CA125、CEA급AFP수평균고우대조조,차이유통계학의의(P<0.05),양성솔우우대조조,차이유통계학의의(P<0.05),차CA125、CEA급AFP연합검측적양성솔고우단항검측결과,차이유통계학의의(p<0.05)。결론 CA125、CEA、AFP연합검측유리우제고란소암검출적양성솔,재기림상진단중구유교고개치。
objective: to study the clinical diagnosis value of CA125, CEA and AFP joint examination in the ovarian cancer. methods: selecting 42 cases of ovarian cancer patients for observation group, and selecting 40 cases of ovarian benign tumor patients for control group, the CA125, CEA and AFP level of two groups were compared. Results: the CA125, CEA and AFP level in observation group were higher than control group (P < 0.05), the positive rate was better than control group (P<0.05), and the positive rate of CA125, CEA and AFP united detection was higher than the single test results (P < 0.05). Conclusion:CA125, CEA and AFP joint detection can help improve the positive rate of ovarian cancer detection,had high value in clinical diagnosis.